feedback

Faculty

Baris Turkbey

Molecular Imaging Program
National Cancer Institute
National Institutes of Health
Bethesda, MD

Marcin Czarniecki

Molecular Imaging Program
Center for Cancer Research (CCR)
National Cancer Institute (NCI)
National Institutes of Health (NIH)
Bethesda, MD

Joanna H. Shih

Biometric Research Branch
Division of Cancer Treatment and Diagnosis
NCI, NIH
Rockville, MD

Stephanie A. Harmon

Clinical Research Directorate
Frederick National Laboratory for Cancer Research
Frederick, MD

Piyush K. Agarwal

Urologic Oncology Branch
CCR, NCI, NIH
Bethesda, MD

Andrea B. Apolo

Genitourinary Malignancies Branch
CCR, NCI, NIH
Bethesda, MD

Deborah E. Citrin, MD

Radiation Oncology Branch
Center for Cancer Research
National Cancer Institute
Bethesda, MD

James L. Gulley

Genitourinary Malignancies Branch
CCR, NCI, NIH
Bethesda, MD

Mukesh Harisinghani, MD

Department of Radiology
Massachusetts General Hospital
Department of Radiology
Harvard Medical School
Boston

Ravi A. Madan
Ravi A. Madan, MD

Center for Cancer Research
National Cancer Institute
National Institutes of Health
Bethesda, Maryland

Adam R. Metwalli

Department of Surgery
Division of Urology
Howard University Hospital
Washington, DC

Edmond Paquette

Inova Medical Group Urology
Inova Fairfax Hospital
Fairfax, VA

Peter A. Pinto

Urologic Oncology Branch
CCR, NCI, NIH
Bethesda, MD

Soroush Rais-Bahrami

Department of Urology
Department of Radiology
University of Alabama at Birmingham
Birmingham, AL

Lindsay S. Rowe

Radiation Oncology Branch
CCR, NCI, NIH
Bethesda, MD

Bradford J. Wood

Center for Interventional Oncology
CCR, NCI, NIH
Bethesda, MD

Paula M. Jacobs

Cancer Imaging Program
CCR, NCI, NIH
Bethesda, MD

Liza Lindenberg

Molecular Imaging Program
Center for Cancer Research (CCR)
National Cancer Institute (NCI)
National Institutes of Health (NIH)
Bethesda, MD

William Dahut

Genitourinary Malignancies Branch
CCR, NCI, NIH
Bethesda, MD

Peter L. Choyke

Molecular Imaging Program
Center for Cancer Research (CCR)
National Cancer Institute (NCI)
National Institutes of Health (NIH)
Bethesda, MD

Accredited by

American Roentgen Ray Society

Course Description

After completing the material in this article, the learner should be able to:
1. Identify the advantage of ferumoxytol-enhanced MR lymphography for metastatic lymph nodes; and
2. Describe the appropriate technique and procedures involvement in the implementation of ferumoxytol-enhanced MR lymphography.

Activity Details

Credit Types:CME
Credit Amount:1.00 Credits
Release Date:2019-Dec-20
Expiration Date:2022-Dec-19
Estimated Time for Completion:1 hour
Registration Required:Yes
Cost:$0-$40

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.